Tinnitus
Conditions
Brief summary
The aim of this study is to evaluate the added effect of tDCS to TRT within patients with chronic, non-pulsatile tinnitus. Patients were randomised in two groups namely, TRT and real tDCS and the second one is TRT with sham tDCS. Evaluations took place at the start of therapy, at the end of the counselling and at last a follow-up visit will be planned after 84 days of the start of the therapy. Subjective outcome measurements such as Tinnitus Functional Index and Visual Analogue Scales of loudness are the primary outcome measurement. Secondary outcome measurements are the Hospital Anxiety and Depression Scale, hyperacusis questionnaire and psychoacoustic measurements.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
* Duration of tinnitus \> 6 months * Maximum loudness of tinnitus on the VAS ≥ 4 * TFI score ≥ 25
Exclusion criteria
* Pregnancy * Psychiatric disorders * Pace maker or defibrillator * Pulsatile tinnitus * Acoustic Neurinoma * CVA
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Tinnitus Functional Index (TFI) | 3 months |
Secondary
| Measure | Time frame |
|---|---|
| Hospital Anxiety and depression Scale | 3 months |
| Patient Global Impression of Change | 3 months |
| Hyperacusis Questionnaire | 3 months |
| Late Latency Evoked Potentials | 3 months |
| Visual Analogue Scale of Loudness | 3 months |
| Psychoacoustic measurements | 3 months |
Countries
Belgium